• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用超声造影对肝细胞癌患者经肝动脉化疗栓塞术前、后的微循环血流灌注进行定量分析。

Quantitative analysis of microcirculation blood perfusion in patients with hepatocellular carcinoma before and after transcatheter arterial chemoembolisation using contrast-enhanced ultrasound.

作者信息

Tian Hui, Wang Qi

机构信息

Abdominal Ultrasound Department, the Second Hospital of Hebei Medical University, Shijiazhuang, 050000, PR China.

Abdominal Ultrasound Department, the Second Hospital of Hebei Medical University, Shijiazhuang, 050000, PR China.

出版信息

Eur J Cancer. 2016 Nov;68:82-89. doi: 10.1016/j.ejca.2016.08.016. Epub 2016 Oct 10.

DOI:10.1016/j.ejca.2016.08.016
PMID:27728840
Abstract

To conduct a quantitative analysis of microcirculation blood perfusion in patients with hepatocellular carcinoma (HCC) before and after transcatheter arterial chemoembolisation (TACE) using contrast-enhanced ultrasound (CEUS). From 2013 June to 2105 October, a total of 106 HCC patients undergoing TACE were recruited. CEUS was performed before and after TACE to determine time-intensity curve (TIC) and perfusion quantitative parameters of the HCC lesions and surrounding liver parenchyma. Quantitative perfusion parameters were obtained using the region of interest method. The microcirculation blood perfusion was measured with a blood analysis system and microcirculation microscope. Tumour microvessel density (MVD) was detected by CD34 immunohistochemistry. Compared with surrounding liver parenchyma, the HCC lesions had earlier arrive time (AT), time to initial peak (TTP) and acceleration time, and faster slope of rise time (a3), but no differences were observed in mean transit time (MTT), slope of decrease to half of peak (a2), peak intensity (PI), increased signal intensity (ISI), area under the curve (AUC) and blood flow (BF). There were significant differences in PI, a3, ISI, AUC and BF in HCC lesions between before and after TACE. The high blood viscosity, low blood viscosity, plasma viscosity and integral viscosity in HCC lesions increased after TACE, but the velocity of nailfold microcirculation decreased after TACE. The MVD of well-differentiated HCC lesions was higher than that of poor-differentiated HCC lesions under a light microscope at 50× magnification. However, no significant differences were found in MVD between well-differentiated and poor-differentiated HCC lesions under a light microscope at 100× and 200× magnifications. The PI, ISI, AUC and BF of poor-differentiated HCC lesions were significant lower than those of well-differentiated HCC lesions, but there were no differences in AT, TTP, ACU, MTT, a2 and a3. In conclusion, these results indicate that quantitative CEUS perfusion parameters could be useful tools for assessing the efficacy of TACE for HCC.

摘要

采用超声造影(CEUS)对肝细胞癌(HCC)患者经动脉化疗栓塞术(TACE)前后的微循环血流灌注进行定量分析。2013年6月至2015年10月,共招募了106例行TACE的HCC患者。在TACE前后进行CEUS,以确定HCC病灶及周围肝实质的时间-强度曲线(TIC)和灌注定量参数。使用感兴趣区域法获得定量灌注参数。用血液分析系统和微循环显微镜测量微循环血流灌注。通过CD34免疫组化检测肿瘤微血管密度(MVD)。与周围肝实质相比,HCC病灶的到达时间(AT)、达初始峰值时间(TTP)和加速时间更早,上升时间斜率(a3)更快,但平均通过时间(MTT)、下降至峰值一半的斜率(a2)、峰值强度(PI)、信号增强强度(ISI)、曲线下面积(AUC)和血流量(BF)无差异。TACE前后HCC病灶的PI、a3、ISI、AUC和BF有显著差异。TACE后HCC病灶的高切黏度、低切黏度、血浆黏度和全血黏度升高,但甲襞微循环速度降低。在50倍光镜下,高分化HCC病灶的MVD高于低分化HCC病灶。然而,在100倍和200倍光镜下,高分化和低分化HCC病灶的MVD无显著差异。低分化HCC病灶的PI、ISI、AUC和BF显著低于高分化HCC病灶,但AT、TTP、ACU、MTT、a2和a3无差异。总之,这些结果表明,CEUS定量灌注参数可能是评估TACE治疗HCC疗效的有用工具。

相似文献

1
Quantitative analysis of microcirculation blood perfusion in patients with hepatocellular carcinoma before and after transcatheter arterial chemoembolisation using contrast-enhanced ultrasound.使用超声造影对肝细胞癌患者经肝动脉化疗栓塞术前、后的微循环血流灌注进行定量分析。
Eur J Cancer. 2016 Nov;68:82-89. doi: 10.1016/j.ejca.2016.08.016. Epub 2016 Oct 10.
2
Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial Chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): a feasibility study.应用超声造影剂增强超声(CEUS)评价和定量分析可降解淀粉微球经肝动脉化疗栓塞术(DSM-TACE)治疗肝癌过程中微血管变化的可行性研究。
Clin Hemorheol Microcirc. 2013;53(4):337-48. doi: 10.3233/CH-2012-1555.
3
Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.超声造影(CEUS)容积导航图像融合与计算机断层扫描(CT)或磁共振成像(MRI)在肝癌(HCC)经导管动脉化疗栓塞(TACE)后的介入后随访中的应用:初步结果。
Clin Hemorheol Microcirc. 2010;46(2-3):101-15. doi: 10.3233/CH-2010-1337.
4
[Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].全肝CT灌注成像对肝癌经导管动脉化疗栓塞术后肝脏血流状态定量评估的诊断价值
Zhonghua Gan Zang Bing Za Zhi. 2018 Jun 20;26(6):429-435. doi: 10.3760/cma.j.issn.1007-3418.2018.06.008.
5
Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.容积灌注计算机断层扫描与对比增强超声评估肝细胞癌患者经动脉化疗栓塞治疗效果的比较:初步报告
Acta Radiol. 2016 Jan;57(1):8-12. doi: 10.1177/0284185114566442. Epub 2015 Jan 13.
6
Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data.经导管肝动脉化疗栓塞术(DEB-TACE)中应用经动脉和静脉对比剂增强超声评估载药微球(DEB)的肝细胞癌微循环:初步数据。
Clin Hemorheol Microcirc. 2011;49(1-4):55-66. doi: 10.3233/CH-2011-1457.
7
Early evaluation of treatment response to transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The role of dynamic three-dimensional contrast-enhanced ultrasound.早期评估晚期肝细胞癌患者经动脉化疗栓塞治疗反应:动态三维对比增强超声的作用。
Clin Hemorheol Microcirc. 2021;78(4):365-377. doi: 10.3233/CH-201086.
8
Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.基于双期增强 CT 图像数据的纹理分析参数评价在药物洗脱微球经导管动脉化疗栓塞术(DEB-TACE)治疗肝细胞癌患者中的疗效预测:与肝灌注 CT 的相关性。
Acad Radiol. 2017 Nov;24(11):1352-1363. doi: 10.1016/j.acra.2017.05.006. Epub 2017 Jun 23.
9
Computed tomographic perfusion with 160-mm coverage: comparative analysis of hepatocellular carcinoma treated by two transarterial chemoembolization courses relative to magnetic resonance imaging findings.160 毫米覆盖范围的计算机断层灌注:两种经动脉化疗栓塞术治疗的肝细胞癌与磁共振成像结果的对比分析。
Abdom Radiol (NY). 2019 Jan;44(1):85-94. doi: 10.1007/s00261-018-1714-x.
10
Color coded perfusion imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following trans-arterial chemoembolization (TACE) of hepatocellular carcinoma.超声造影彩色编码灌注成像用于肝癌经动脉化疗栓塞(TACE)后介入治疗效果的控制。
PLoS One. 2019 Jun 10;14(6):e0217599. doi: 10.1371/journal.pone.0217599. eCollection 2019.

引用本文的文献

1
miR-183-5p-enriched extracellular vesicles promote the crosstalk between hepatocellular carcinoma cell and endothelial cell via SIK1/PI3K/AKT and CCL20/CCR6 signaling pathways.富含miR-183-5p的细胞外囊泡通过SIK1/PI3K/AKT和CCL20/CCR6信号通路促进肝癌细胞与内皮细胞之间的串扰。
Front Oncol. 2025 Mar 6;15:1532239. doi: 10.3389/fonc.2025.1532239. eCollection 2025.
2
Potential therapies for HCC involving targeting the ferroptosis pathway.涉及靶向铁死亡途径的肝癌潜在治疗方法。
Am J Cancer Res. 2024 Apr 15;14(4):1446-1465. doi: 10.62347/SIGP9279. eCollection 2024.
3
Correlations between contrast-enhanced ultrasound and microvessel density in non-small cell lung cancer: A prospective study.
非小细胞肺癌中超声造影与微血管密度的相关性:一项前瞻性研究。
Front Oncol. 2023 Mar 2;13:1086251. doi: 10.3389/fonc.2023.1086251. eCollection 2023.
4
Current aspects of multimodal ultrasound liver diagnostics using contrast-enhanced ultrasonography (CEUS), fat evaluation, fibrosis assessment, and perfusion analysis - An update.多模态超声肝脏诊断的当前方面:对比增强超声(CEUS)、脂肪评估、纤维化评估和灌注分析 - 更新。
Clin Hemorheol Microcirc. 2023;83(2):181-193. doi: 10.3233/CH-239100.
5
Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis.基于动态对比增强超声定量分析预测胰腺神经内分泌肿瘤的病理分级
Diagnostics (Basel). 2023 Jan 9;13(2):238. doi: 10.3390/diagnostics13020238.
6
Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma.铁死亡:从肝细胞癌的基础研究到临床治疗
J Clin Transl Hepatol. 2023 Feb 28;11(1):207-218. doi: 10.14218/JCTH.2022.00255. Epub 2022 Aug 31.
7
Clinical value of contrast-enhanced ultrasound in early diagnosis of small hepatocellular carcinoma (≤ 2 cm).超声造影在小肝癌(≤2cm)早期诊断中的临床价值
World J Clin Cases. 2022 Aug 26;10(24):8525-8534. doi: 10.12998/wjcc.v10.i24.8525.
8
CircCRIM1 Promotes Hepatocellular Carcinoma Proliferation and Angiogenesis by Sponging miR-378a-3p and Regulating SKP2 Expression.环状CRIM1通过吸附miR-378a-3p并调节SKP2表达促进肝细胞癌增殖和血管生成。
Front Cell Dev Biol. 2021 Nov 12;9:796686. doi: 10.3389/fcell.2021.796686. eCollection 2021.
9
Design of Liver Functional Reserve Estimation Technique Based on Optical Densitometry.基于光密度法的肝储备功能评估技术设计
Diagnostics (Basel). 2020 Aug 16;10(8):599. doi: 10.3390/diagnostics10080599.
10
Safety and effectiveness of multi-antenna microwave ablation-oriented combined therapy for large hepatocellular carcinoma.多天线微波消融导向联合治疗大肝癌的安全性与有效性
Therap Adv Gastroenterol. 2019 Aug 21;12:1756284819862966. doi: 10.1177/1756284819862966. eCollection 2019.